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Bagaza virus (BAGV) is a mosquito-borne flavivirus belonging to the Ntaya serocomplex. In 2010, a disease outbreak
was reported in Cádiz (Southern Spain) affecting game birds (red-legged partridges and common pheasants). In this
work, red-legged partridges were inoculated experimentally with infectious BAGV isolated from this outbreak in order
to make a complete clinical and analytical assessment of the disease caused by the pathogen in this species. Viral load
(by real-time RT-PCR) in blood, oral and cloacal swabs, and feathers, and neutralizing antibody titres (by VNT)
were measured. In order to determine direct contact transmission, non-inoculated partridges were caged together
with the inoculated ones. To assess infectiousness in other species, house sparrows and mice were also inoculated with
the virus. All the inoculated partridges were clinically affected, and 30% of them died. All the infected individuals lost
weight, with larger losses being recorded in females. Conversely, no mortality or disease symptoms were observed in
the sparrows or mice. Remarkably, all the contact partridges acquired the infection by direct (non-vectored)
transmission. This study confirms that the red-legged partridge is a susceptible host for BAGV infection, and that
this pathogen is transmitted by direct contact. Long-lasting viral loads detected in calami of immature feathers
demonstrate that feather sampling could be a useful strategy in active surveillance programs for early detection
of BAGV.Introduction
The incidence and geographical distribution of mosquito-
borne epornitic flaviviruses have increased in the last dec-
ade in different parts of the world [1]. Europe and the
Mediterranean Basin constitute good examples of the re-
cent introduction and geographical spread of these types
of flaviviruses, which are of concern for both animal and
human health, e.g. West Nile and Usutu viruses [1-4].
Likewise, other flaviviruses have also appeared recently be-
yond their known geographic ranges. This is the case of
Bagaza Virus (BAGV), belonging to the Ntaya serocom-
plex, in Southern Spain in September 2010, associated* Correspondence: majimenez@inia.es
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tridges (Alectoris rufa) and ring-necked pheasants (Pha-
sianus colchicus) [5]. This outbreak was the first one of
BAGV detected in Europe, and enabled its first isola-
tion from a vertebrate host. Although no clinical dis-
ease has been reported since the outbreak in 2010,
specific Bagaza virus-neutralizing antibodies were de-
tected in 2011–2012 in shot birds from both species in
the same region, including juvenile partridges suggesting
continued circulation of the virus [6].
BAGV was first isolated in the Central African
Republic in 1966, from a pool of Culex mosquitoes [7].
Subsequently, it was detected in mosquitoes in other
countries in Western Africa [8-10] and India [11]. A com-
parison of full-length sequences indicates that BAGV and
Israel turkey meningoencephalomyelitis virus (ITV), a
pathogen affecting turkeys reported in Israel and Southle is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
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meningoencephalomyelitis virus (AMEV) was proposed to
unify them [12].
Information on the pathogenesis of BAGV has recently
been obtained from natural Bagaza infection during the
outbreak in Southern Spain in 2010 [13-15]. As regards
experimental infections, previous studies have been
mainly limited to old ITV and BAGV strains inoculated
in domestic turkeys [16] and mice [17], while experi-
mental inoculations of recent BAGV strains are lacking.
Therefore, the first aim of this study was to assess if a
BAGV isolate from a recent European outbreak is able
to reproduce, under experimental conditions, the disease
observed in the field in the same bird species from
which it was isolated.
Hence, the course of the viremia, seroconversion,
viral distribution in organs/tissues and virus shedding
through different routes were examined in red-legged
partridges in order to gain knowledge about BAGV
pathogenicity and tissue tropism in this species, and its
role as a reservoir host. Possible contact transmission
and the usefulness of different samples for diagnosis
were also studied. Moreover, the same BAGV isolate was
inoculated in the house sparrow (Passer domesticus) and
in mice (Mus musculus) in order to assess its infectious-
ness and pathogenicity in these species and to further
assess the host range for this virus.
Materials and methods
Virus isolation and preparation of inocula
The virus used in the inoculations was isolated from the
heart of a partridge found dead in the outbreak regis-
tered in Southern Spain in 2010 [2]. The original tissue
(heart) was homogenized, clarified and inoculated in
BSR cells (clone of BHK-21 cell line). After two passages
in BSR and four passages in Vero cells, a cytopathic ef-
fect was observed in the cell cultures, from which the
virus was recovered, grown and titrated by plaque assay
in Vero cells as previously described [18]. The isolated
virus, named BAGV Spain RLP-Hcc2/2010, was com-
pletely sequenced [GenBank:KR108245]).
Birds and mice
Red-legged partridges
Five-month-old red-legged partridges (Alectoris rufa)
(n = 30) were obtained from the Lugar Nuevo red-legged
partridge breeding facility (Estación de Referencia de la
Perdiz Roja, Consejería de Medio Ambiente y Ordenación
del Territorio-Junta de Andalucía, Andujar, Spain, 38°16′
N 4°6′W), which guarantees the lack of hybridization with
other partridge species. Prior to the experiment, all indi-
viduals were tested serologically using a commercially
available competitive ELISA (Ingezym West Nile Compac,
INGENASA, Madrid, Spain) and virologically (by real-timeRT-PCR as described below) to ensure that previous
exposure to BAGV or other flaviviruses had not occurred.
The partridges were transported to the biosafety level 3
(BSL-3) facilities at CISA (Centro de Investigación en
Sanidad Animal, Valdeolmos, Spain). After careful depara-
siting, the birds were distributed in three wire mesh cages
(120 × 40 × 40 cm) in experimental groups, (see below this
section, under “Experimental inoculation”), composed of
50% males and 50% females (estimated considering body
size and presence of spur, and confirmed after necropsy at
the end of the experiment). The birds were provided with
a commercial diet for game birds and water ad libitum
throughout the experiment.
House sparrows
Free-living house sparrows (Passer domesticus) were
captured using mist nets and banded in Southern Spain
(Seville) and adapted to captivity for two months in out-
door cages. The sparrows were transported to the BSL-3
facilities at CISA, deparasited and housed in individual
wire cages (45 × 40 × 30 cm) and tested serologically and
virologically to discard previous exposure to flavivirus,
as explained above for red-legged partridges. The spar-
rows were provided with mixed bird food and water ad
libitum.
Mice
Three-week-old Swiss HSD ICR (CD1) outbred female
mice were purchased from Harlan Inc. (Switzerland) and
kept in the CISA BSL-3 facility until their inoculation at
the age of 4 weeks.
Animal care, handling and experimental procedures
were authorized by the INIA Committee of Ethics and
Animal Experimentation (Reference codes: BV/Pe-1,
BV/Go-1 and BV/Mo-1) according to European and
Spanish laws on the protection of animals for experi-
mental and other scientific purposes (Spanish Royal
Decree 53/2013 and Council Directive 2010/63/EU).
Experimental inoculations
After 7 days for acclimatization, the birds and mice were
inoculated with BAGV (strain Spain RLP-Hcc1/2010)
diluted in up to 0.1 mL in Dulbecco’s Minimum Essential
Medium (DMEM) (supplemented with 2 mM L-glutamine,
100 U/mL penicillin and 100 μg/mL streptomycin).
Distribution of animals in experimental groups: One
group composed of 10 red-legged partridges (inoculated
group) and another group of 6 birds (programmed nec-
ropsy group) were inoculated subcutaneously in the neck
with approximately 2 × 105 pfu (plaque-forming units) of
BAGV/individual. Both groups were kept in separated
cages. A third group, consisted of four non-inoculated par-
tridges (contact group), was kept with the inoculated group,
in the same cages. One additional group of partridges
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equivalent volume of DMEM and kept in a separate cage.
Eight house sparrows were inoculated subcutane-
ously in the neck with approximately 2 × 105 pfu/indi-
vidual of BAGV whereas another group (n = 8) was
sham-inoculated and used as control. All the sparrows
were kept in individual cages.
Four groups, each consisting of two 4-week-old mice
were inoculated intraperitoneally with tenfold dilution
doses of BAGV ranging from 5 × 102 to 5 × 105 pfu/individ-
ual. The control group was composed of two mice that
were sham-inoculated and housed in a different cage.
Clinical follow-up and collection of samples
Red-legged partridges
Disease symptoms were observed daily for up to 15 days
post-inoculation (dpi) in the inoculated and control
groups and for up to 18 dpi in the contact group. To fol-
low the viremia course, blood samples were collected at 1,
3, 5, 7, 9, 11 and 15 dpi in the inoculated and control
groups and at 3, 5, 7, 9, 11, 15 and 18 dpi in the contact
group. Blood samples (0.1 mL) were collected in sterile
polypropylene tubes filled with 0.9 mL BA-1 diluent
(Hanks M-199 salts, 0.05 M Tris, pH 7.6, 1% bovine
serum albumin, 0.35 g/L of sodium bicarbonate, 100
units/mL of penicillin, 100 μg/mL of streptomycin, 1 μg/
mL of amphotericin B) and stored at −70 °C until analysis.
A second blood sample (0.1-0.2 mL/ individual) was taken
in dry tubes and allowed to clot at 37 °C for 1 h, followed
by incubation at 4 °C overnight, to obtain serum. Simi-
larly, immature rump feathers, oropharyngeal and cloacal
swabs were collected one day before inoculation, and on
the same days post-infection as blood sampling, in all
groups.
Swabs were placed in sterile polypropylene tubes contain-
ing 1 ml PBS, while feathers were collected in empty sterile
polypropylene tubes, and both were stored at −70 °C until
analysis. Following death, the partridges were necropsied
within <18 h. Individuals from the programmed necropsy
group were euthanized humanely by intravenous injec-
tion of embutramide (T61 ®, Intervet - Schering-Plough,
Madrid, Spain) on days 4, 7 and 10 dpi (2 birds each
day) and subjected to full necropsy. Similarly, survivors
from the inoculated and contact groups were eutha-
nized at 15 and 18 dpi respectively. During necropsy,
tissue samples (approximately 0.1 g) from the brain,
heart, kidney, spleen and liver were collected for real-time
RT-PCR analysis, using single-use scalpels and forceps to
avoid cross-contamination, and placed in tubes containing
0.9 mL of PBS.
House sparrows
The house sparrows were monitored daily for up to 14
dpi. Blood samples (0.1 mL) were collected from thejugular vein at 1, 3, 5, 7, 9 and 15 dpi for viremia deter-
mination and at the end of the experiment for antibody
detection, as described above for red-legged partridges.
The birds were euthanized and necropsied as described
previously for partridges.Mice
The mice were monitored daily for symptoms for up to
3 weeks after inoculation (when they were euthanized).
Blood samples were collected at 3 dpi (for viremia deter-
mination) and at 21 dpi for antibody detection in serum.Viremia, BAGV genome load and complete sequence
analyses
BAGV viremia was measured by standard plaque-
formation assays as described [18], while the viral gen-
ome load was measured in blood by semiquantitative
real-time RT-PCR, using a previously described method
[19]. A Ct = 40.0 was set as cut-off to consider the samples
as positives for virus detection by real-time RT-PCR. Tis-
sues, feathers, oropharyngeal and cloacal swabs were
examined using the same RNA extraction method and the
above described real-time RT-PCR, but following a dif-
ferent preparation step depending on the type of sam-
ple. Calami were separated from feathers and placed
in tubes containing 0.9 mL of PBS (one calamus per
sampling day and animal). Tissues from necropsies
and calami in PBS were homogenized for 2 min at
30 cycles/s using a Tissuelyser homogenizer (QIA-
GEN), followed by a centrifugation step at 850 × g
10 min to clarify homogenates. Swabs were directly
clarified at 9500 g for 5 min. One of the tissue sam-
ples with the highest viral genome load (brain from
partridge n° 7) was subjected to complete genome sequen-
cing [GenBank:KR108246]).Antibody detection assays
Virus-neutralizing antibodies to BAGV in serum were
detected and titrated by a virus-neutralization test (VNT)
as described [20]. Neutralization titres were assigned
based on the highest dilution of each serum capable of
neutralizing the infection, i.e. abolishing any observable
CPE in the cell monolayer.Statistical analysis
Comparisons of survival rates between inoculated and
control groups were carried out using the Gehan-Breslow-
Wilcoxon method [21]. Weight loss (% initial weight),
viremia (pfu/mL), and genome load (Ct value) data
between groups were compared using Student’s t-test for
independent groups for the different sampling days.
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Figure 1 Mortality after inoculation of BAGV in red-legged
partridges. Percentage of survivors observed at different days
post-inoculation. Closed circles represent BAGV-inoculated partridges.
Open squares represent sham-inoculated partridges.
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Pathogenicity and clinical signs
The BAGV Spain RLP-Hcc2/2010 strain was pathogenic
for the red-legged partridge, with an observed mortality
of 30% (3 out of 10 BAGV-inoculated partridges) which
occurred between 6 and 10 dpi (Table 1, Figure 1), while
no morbidity or mortality was registered in the non-
inoculated (control) group. However, and considering
the limited number of birds by group, differences
observed in survival rates between inoculated and con-
trol group were not statistically significant (p > 0.05).
Partridges from the inoculated group showed apathy,
reluctance to move, weakness, unresponsiveness and
behavioral changes (e.g. lack of avoidance to capture).
Some individuals also presented partially closed eyes.
From 7 days post infection to the end of the experiment,
all inoculated partridges showed a significant body
weight loss (between 7 and 23% of initial weight) as
compared to the control group (p < 0.00001 from 7 to 15
dpi). Indeed, female partridges suffered a significantly
more pronounced and prolonged weight loss than males
at 11 dpi (p = 0.004) and 15 dpi (p = 0.041) (Figure 2).
In the case of inoculated sparrows and mice, no mor-
tality or signs of disease were observed throughout the
experiment (Table 1).
Viremia
Viral genome in blood was detectable in partridges from
1 to 11 dpi (Figure 3). However, viremia (measured by
standard plaque-formation) could only be detected at 3
and 5 dpi (Figure 3B). Both viremia titres (1.8 × 105 pfu/
mL) and viral genome load peaked at 3 dpi. In blood
samples with a Ct > 34, the virus was not detected by
standard plaque formation, which indeed confirms a
higher sensitivity of the real time RT-PCR assay used in
this study over plaque assay for virus detection in blood.
In the house sparrows, blood samples collected at 1, 3,
5, 7 and 9 dpi, were negative for BAGV viral genome
assessed by real time RT-PCR, and the same result wasTable 1 Summary of viral inoculations performed in this
work
Species Inoculum
BAGV
Mortality
rate
Mean viral load in
blood 3dpi (Ct)
Ab titre
range
Partridge 2 × 105 0.3 (3/10) 23.2 320 - 1280
House sparrow 2 × 105 0 (0/8) >40 <10
Mouse 5 × 102 0 (0/2) >40 <10
5 × 103 0 (0/2) >40 <10
5 × 104 0 (0/2) >40 <10
5 × 105 0 (0/2) >40 10 - 20
Inoculated doses per individual are indicated as pfu; the mean viral load in
blood was measured by real-time RT-PCR at 3 days post-infection (dpi) and
the antibody (Ab) titre was determined by virus-neutralization test (VNT) at the
end of the experiment.observed in blood samples from mice collected at 3 dpi
(Table 1 and data not shown).Serology
BAGV-neutralizing antibodies (NtAb) were observed in
all partridges surviving the infection. NtAb were first
detected at 5 dpi and were observed in all the partridges
by 7 dpi with titres ranging from 1:160 to 1:320 and
reaching maximum titres (up to 1:1280) at the end of
the experiment (Figure 4 and Table 1). In contrast, NtAb
were absent from the blood of the inoculated house
sparrows at 15 dpi (Table 1). As for the mice, only those
inoculated with the highest dose (5 × 105 pfu) developed70
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Figure 2 Weight loss of red-legged partridges after inoculation
with BAGV. The course of the variation in weight in the different
groups of red-legged partridges, expressed as the percentage of
initial weight (i.e. weight measured on the day of inoculation),
measured at different days post-inoculation. Circles indicate male
and squares female. Closed symbols represent BAGV-inoculated
partridges, while open symbols represent sham-inoculated partridges.
Error bars represent the standard error of the mean.
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Figure 3 Mean daily blood viral genome load and viremia titres for BAGV-inoculated red-legged partridges. The course of A blood viral
genome load and B viremia titres during the experiment of BAGV inoculation in red-legged partridges, determined at different days post-inoculation.
Each point represents the mean obtained for the surviving individuals at different times post-inoculation. Error bars represent the standard error of
the mean.
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1:20), the rest being negative (titre <1:10).Virus shedding and viral load in feathers
In the inoculated red-legged partridges, virus shedding
was shown to occur from 3 to 11 dpi through the cloacal
and oral routes, reaching a maximum at 5 dpi, but it
was more consistently detected in oropharyngeal than in
cloacal swabs (Figure 5).
The viral genome load in feathers reached a peak also
at 5 dpi, but it was found to be considerably higher and
was detectable for a longer period than in blood and in
both types of swabs examined. At 15 dpi, the virus0
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Figure 4 Antibody response to BAGV in serum from BAGV-
inoculated red-legged partridges. The course of the antibody
response in the individuals inoculated with BAGV, measured on
different days post-inoculation, is plotted as a solid line with open
squares representing the mean log titres of BAGV-neutralizing
antibodies measured in the virus-neutralization test (VNT). Error
bars represent the standard deviation of the data.genome was still detectable in feathers, while in the
swabs, no virus genome was observed beyond 11 dpi.
Virus distribution in organs
The post-mortem examination of the lethally infected
red-legged partridges revealed systemic infection, as the
virus was detected by real-time RT-PCR in all organs
examined, including the brain, heart, spleen, kidney and
liver (Table 2). In order to assess the extent of virus dis-
tribution in organs at different times post-infection,
viral loads were compared in organs collected from
BAGV-inoculated birds subjected to programmed necrop-
sies at 4, 7 and 10 dpi and from the birds surviving the
infection after 15 dpi. While in the heart, kidney, spleen
and liver, the highest viral loads were found at 4 dpi, that
is, only 1 day after the viremia peak, the maximum viral17
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Figure 5 Viral genome load in swabs (oral, cloacal) and
feathers from BAGV-inoculated red-legged partridges. The
course of the viral RNA load in each type of sample, measured by
real-time RT-PCR specific for BAGV, is represented on different days
post-inoculation. Open squares indicate viral load in oral swabs;
closed squares viral load in cloacal swabs and closed circles viral
load in feathers. Error bars represent standard error of the mean.
Table 2 BAGV detection by real time RT-PCR in organs
from inoculated red-legged partridges
Partridge Sex dpi Viral load in organs (Ct)
Brain Heart Kidney Spleen Liver
N 1 female 4 29 19 21 21 21
N 4 male 4 30 25 23 23 22
4* female 6 27 23 23 23 24
N 2 female 7 22 22 22 24 23
N 5 male 7 27 23 25 27 30
10* male 7 24 21 25 24 25
N 3 female 10 30 29 27 32 31
N 6 male 10 26 28 23 29 33
7* male 10 21† 26 25 28 33
1 male 15 34 >40 37 34 >40
2 female 15 31 32 31 29 37
3 female 15 33 32 32 32 37
5 female 15 31 32 32 31 34
6 male 15 33 35 34 30 38
8 male 15 31 32 30 30 38
9 male 15 35 35 34 31 35
Individual partridges are numbered correlatively (N indicates partridges in the
programmed necropsy group). The table indicates the sex of the sampled
partridges, the day post infection (dpi) when the samples were obtained and
the corresponding viral load expressed in Ct (threshold cycle) obtained by
real-time RT-PCR analysis, for the different organs examined.
*Lethally infected birds; †Complete sequence analyzed.
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7–10 dpi. After that, over time, the viral genome load
declined, but at day 15 post infection, the virus could still
be detected in most organs (see Additional file 1).
One of the tissue samples examined (the brain from
the necropsy of partridge 7, which died at 10 dpi) which
showed a high viral genome load (Ct = 21) (Table 2)
was chosen for further genetic characterization by
complete sequence analysis. The sequence obtained
(GenBank:KR108246), was identical to the complete se-
quence of the BAGV strain used for the inoculation
(GenBank:KR108245).
Contact transmission in red-legged partridges
None of the four contact partridges died during the ex-
periment. However, all of them showed viremia, viral
shedding through the oral and cloacal routes and the
presence of virus in feathers. Furthermore, three of them
suffered important body weight loss and developed neu-
tralizing antibodies. The presence of viral RNA was
confirmed in all analyzed tissues at the end of the ex-
periment (Table 3).
Three out of four contact partridges showed a delay of
5 to 9 days in the development of disease signs and evi-
dence of infection (viral load, antibodies in serum andweight loss), as compared to inoculated birds (Table 3).
In one of these contact partridges (contact 3), a viral
load in oral swab was detected four days before it be-
came viremic. In the fourth contact partridge, signs of
the disease and evidence of infection appeared approxi-
mately 13 days later than in the inoculated group.
Discussion
To our knowledge, this study is the first one describing an
experimental infection with BAGV in a European wild
bird species, the red-legged partridge. In laboratory-
controlled conditions, the study demonstrated that this
species is susceptible to BAGV infection and, as a con-
sequence, develops a disease with signs compatible with
those observed in field conditions in the outbreak in
Cádiz, Spain, in 2010 [13]. Therefore, Bagaza virus was
concluded to be the causative agent of this disease. The
virus appeared to be rather stable as its complete gen-
ome sequence, obtained from the brain of one of the
clinically affected partridges, was identical to the gen-
ome sequence of the virus strain used in the inoculum.
In contrast, under the experimental conditions assayed,
the virus affected neither house sparrows nor mice,
which presumably reflects some sort of resistance to
the infection in these species that can rely on their gen-
etic background and/or innate immune mechanisms. A
role for adaptive (humoral) immunity was specifically
discarded, since all the animals were found to be nega-
tive for specific BAGV antibodies prior to inoculation.
In the outbreak in Southern Spain in 2010, BAGV not
only affected red-legged partridges but also two other wild
bird species: the common pheasant (Phasianus colchicus)
and, to a lesser extent, the common wood pigeon
(Columba palumbus) [13]. Other avian species, such
as the domestic turkey (Melleagris gallipavo) or the
Japanese quail (Coturnix coturnix), were proven sus-
ceptible to natural and experimental infection caused
by old strains of the synonymous virus ITV [16,22,23]
whereas chickens (except one-day-old chicks), ducks
and pigeons were not susceptible [23]. Therefore, the
host range of BAGV seems to mainly include members of
the Phasianidae family, comprising partridges, turkeys,
pheasants, quails and chickens. This study further sup-
ports this host range, since red-legged partridges, but not
house sparrows, where shown susceptible to the disease. It
is worth noting that the BAGV host range differs in this
regard from that of WNV, which includes passerines like
the house sparrow [24,25].
Regarding mammals, suckling mice had been shown
susceptible to infection and disease after experimental
inoculation of an Indian BAGV strain using the Culex
tritaniorhynchus mosquito as the vector [17]. Experi-
ments performed with an old ITV strain (1960) showed
that it could be transmitted (although at low rates) to
Table 3 Summary of the main results obtained in contact partridges
Contact 1 Contact 2 Contact 3 Contact 4
dpi 7 9 11 15 18 7 9 11 15 18 7 9 11 15 18 7 9 11 15 18
% init. weight 96 94 91 81 83 98 97 98 100 96 98 97 97 91 76 99 99 100 90 91
VNT titre <10 <10 20 640 320 <10 <10 <10 <10 <10 <10 <10 <10 80 320 <10 <10 <10 160 320
VL blood (Ct) 29 30 32 39 38 >40 >40 >40 26 29 >40 >40 25 33 38 >40 25 20 33 35
VL oral. (Ct) 37 28 24 29 >40 >40 >40 >40 >40 25 33 >40 33 28 31 >40 33 28 28 36
VL cloacal (Ct) >40 >40 >40 >40 >40 >40 >40 >40 >40 28 >40 >40 >40 37 >40 >40 >40 37 >40 36
VL feather (Ct) 34 20 20 24 37 >40 >40 >40 25 20 >40 >40 23 21 23 >40 35 19 22 24
Contact 1 Contact 2 Contact 3 Contact 4
VL in organs (18 dpi) brain heart kidney spleen liver brain heart kidney spleen liver brain heart kidney spleen liver brain heart kidney spleen liver
32 33 32 34 36 19 19 20 25 21 23 32 25 22 33 28 26 26 29 32
The upper part of the table shows the values obtained from the four contact partridges on different days post-inoculation (dpi) for the following parameters: percentage of weight compared to initial weight at day 0
(% init. weight); neutralizing antibody titre in serum measured by the virus neutralization test (VNT titre); viral load (VL) in blood, oral and cloacal swabs and in feathers, as measured by real time RT-PCR, expressed in
Ct values. The bottom part of the table shows the observed viral load (VL) measured by real-time RT-PCR (expressed in Ct values) in five different organs (the brain, heart, kidney, spleen and liver) at the time of necropsy of
the contact partridges (18 dpi) (neg = Ct ≥40).
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adult mice, ITV inoculation caused mortality when
inoculated by intracerebral or intranasal routes but not
when intraperitoneal or subcutaneous routes were used.
This strain did not produce illness in adult hamsters or
guinea pigs after intracranial inoculation [23,26]. In
keeping with these previous observations, our results
further suggested that BAGV has little effect, if any, on
intraperitoneally inoculated adult mice.
Clinical signs observed in red-legged partridges during
the experiment (weakness, reluctance to move, lack of
avoidance to capture, and partially closed eyes) corre-
lated well with neurologic signs and apparent blindness
registered in natural infections [13,14]. However, the
observations made under experimental conditions might
not completely mimic what occurs in nature. The mor-
tality rate in the inoculated partridges was 30%, but mor-
bidity reached 100%, as all inoculated birds suffered
significant weight loss. It is very likely that individuals
that survived the experimental infection but suffered
clinical illness would probably have died in the wild as a
result of difficulties with feeding and/or escaping from
predators. Viral pathogenicity evaluation in experimental
trials is usually based on survival rates. Nevertheless,
when experimental infections are performed in wild
birds, the number of individuals is often limited due to
animal welfare restrictions and logistic constraints
derived from the wild origin of birds [27]. Consequently,
statistically significant differences in mortality rates
between groups are frequently difficult to observe. In
this study, we evaluated not only mortality rates but also
a morbidity index i.e. body weight loss, which proved to
be a good indicator of disease severity and revealed dra-
matic differences between inoculated and control groups
during the acute phase of the infection. This observation
suggests that the accurate evaluation of quantitative
indexes of morbidity, such as weight, can be useful to
properly evaluate the pathogenicity of virus strains in an
experimental setting.
Based on the data obtained on viremia, viral load in
blood, oral and cloacal swabs, and feathers, the course of
BAGV infection was similar to what has been described
for the West Nile virus in partridges and corvids
[28-30]. The delayed course of the viral load observed in
the brain with respect to other peripheral organs sug-
gested that crossing the blood–brain barrier is a late
event during the infection. Persistent infections by other
flaviviruses have been involved in alternative modes of
transmission by predation of the affected avian hosts
[31]. In our study, the BAGV genome was present in
organs and feathers up to 15 dpi, but to properly assess
this point, it would be necessary to carry out more pro-
longed experiments with higher number of birds. Des-
pite similarities found in neutralizing antibody responsesof red-legged partridges infected with BAGV and WNV
[29], antibodies appeared slightly earlier (at 7 dpi) and
reached higher titres at 15 dpi of BAGV infection as
compared to the WNV infection.
In this work, female partridges showed greater and
more prolonged body weight loss after infection than
males. A greater impact on female pheasants was also
reported during the outbreak of BAGV in Spain, causing
a reduction from 4 to 2.4 in the female/male ratio of
hunted pheasants during the following hunting season
[13]. Also in South Africa, a higher impact of illness in
female turkeys was registered for the synonymous ITV
[22]. However, the reason for this difference is still
unclear.
BAGV-inoculated partridges showed a viremia peak
higher than 105 pfu/mL. The viremia level necessary for
BAGV infection of feeding mosquitoes has not been
determined, but 104-105 pfu/mL is the threshold of
infectious viremia that has been experimentally estab-
lished for other flaviviruses such as WNV to transmit
the infection to Culex mosquitoes, one of its competent
vectors [32,33]. If a similar threshold is assumed for
BAGV, then the red-legged partridge could be consid-
ered a moderately competent host for BAGV transmis-
sion by mosquito bite, and therefore this species could
play a role as a reservoir or amplifying host in nature.
Viral shedding was higher and more consistent in oral
secretions than in faeces, which is in accordance with
the data obtained in field samples from partridges and
pheasants during the BAGV outbreak [13]. Viral RNA
was detected in feathers of infected birds at higher rates
and for a longer period after infection in comparison
with other samples (blood and swabs), so the feather
could be a convenient sample to monitor virus circulation
in surveillance programs, at least in red-legged partridges.
A much greater viral load in growing feathers and with
a longer persistence than in blood has also been found
for Eastern equine encephalitis virus in ring-necked
pheasants, avian leucosis virus in domestic chickens
and West Nile virus in Gyr-Saker hybrid falcons
[34,35]. Viral detection in vascular and non-vascular
feathers of corvid carcasses has been proposed as useful
for West Nile virus surveillance [34,36].
Interestingly, in this study, all contact-exposed birds
became viremic and seroconverted, showing a high rate
of contact transmission of BAGV in this host. In order
to remove any potential ectoparasite present, all the
individuals had been treated with pyrethroids before
entering the experimental setting at the BSL3 facilities;
consequently only direct transmission could explain
the infection of contact individuals. In three out of
four contact partridges, the signs of the disease started
with a delay of 5 to 9 days with respect to syringe-
inoculated birds. The high amount of virus present in
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that point suggests that the infection in contact-exposed
birds was probably acquired through oral-oral route or by
skin or feather picking. Viral detection in the oral swab in
a contact partridge 4 days before viremia supports the idea
of infection by the oral route. In the fourth contact par-
tridge, the disease symptoms started 13 days later than in
the syringe-inoculated partridges, suggesting that this par-
tridge could have acquired the infection from the other
contact birds in a second round of contact infection, and
not from the inoculated group. This result contrasts with
our previous observation that WNV was not transmitted
to contact red-legged partridges under analogous experi-
mental conditions [29]. Potential direct transmission of
WNV has been assessed experimentally for at least 24
avian species [27], but contact transmission has only been
demonstrated in five species belonging to three families:
Common goose (Anser anser) [37], ring-billed gull (Larus
delawarensis) and three species of corvids [33]. Neverthe-
less, the contact transmission rate observed in this work
(4 out of 4 contact birds) for BAGV is considerably higher
than that registered for WNV in any of the studied
species.
Although contact transmission has been proposed to
explain the rapid dissemination of ITV strains in turkey
farms [22], this could not be proved in experimental tri-
als and intranasal infection attempts in turkeys were also
unsuccessful [16]. The high transmission rate observed
in the present study suggests that partridges are highly
competent hosts for BAGV contact transmission, and, at
least in this avian species, this transmission route can be
epidemiologically relevant. The red-legged partridge is
one of the most important small game bird species in
Southern Europe and the UK, where restocking of farm-
bred birds for hunting purposes is common. In breeding
farms and, to a lesser extent, in the hunting properties
where game birds aggregate in high densities around
artificial feeders and water points, transmission risk by
direct contact through water/food contamination or fea-
ther picking could be high.
The fact that BAGV has appeared in Southern Europe
just once indicates that its introduction in this contin-
ent is a very unusual event. The BAGV geographic
range includes Sub-Saharan Africa, and consequently,
this area could be a possible origin for the introduction
of BAGV into Spain. This hypothesis, however, needs
to be substantiated, for instance, with sequence data
recent African BAGV strains, but also with a suitable
mechanism of introduction. Viraemic migratory birds
or wind-borne infected mosquitoes have been proposed as
mechanisms mediating the introduction of other flavi-
viruses [38,39]. Nevertheless, other alternative explana-
tions like poultry industry-driven movements or trading
of exotic birds should not be disregarded. Evidence ofBAGV circulation in Southern Spain in two consecutive
seasons [6] supports the possibility of overwintering
after the introduction of the virus and indicates a risk
of expansion in areas with similar climate conditions
and/or similar game bird release programs. Other epor-
nitic arboviruses, such as WNV and USUV have spread
slowly but relentlessly throughout large parts of Europe
[1-4]. BAGV is likely to have a similar potential for dis-
semination, but displaying a more efficient contact trans-
mission, at least in red-legged partridges, a characteristic
that might cause large outbreaks in dense populations of
susceptible birds, such as in farmed game birds, which
could facilitate the adaptation and maintenance of the
BAGV life cycle after a new introduction of the virus, and
eventually the spread of this pathogen when game birds
are released into the wild. Thus, epidemiological surveil-
lance in these susceptible birds is needed in order to avoid
the introduction, maintenance and spread of the disease.
In other European countries, other birds from the Pha-
sianidae family (grey partridges, pheasants) play the same
role for game as the red-legged partridge, being bred in
captivity and released into the wild for hunting purposes.
Consequently, susceptibility studies on these species are
necessary to estimate to what extent the emergence of
BAGV could affect game birds on the continent.
The emergence of BAGV in Spain has had dramatic
consequences on game bird populations, in which it has
caused high mortality rates, mainly in the red-legged par-
tridge [5], a species with great economic and ecological
value in Europe. Besides its economic importance, the risk
of BAGV for public health is still unknown. On the one
hand, its synonymous virus, ITV, has never been reported
to cause illness in humans, despite circulating in turkeys
in Israel for decades [23,40]; and on the other hand, the
presence of neutralizing Ab against BAGV in humans
with encephalitis suggests infection but not necessarily
pathogenicity [11].
In summary, this study confirms that the red-legged
partridge is susceptible to BAGV infection and disease,
and can be a competent host for both mosquito and dir-
ect (contact) transmission. Consequently, the red-legged
partridge constitutes a suitable target species for BAGV
surveillance. Finally, feather sampling could be a useful
strategy in active surveillance programs for early detec-
tion of BAGV.
Additional file
Additional file 1: BAGV RNA load in organs from inoculated
red-legged partridges. Viral RNA load, expressed as threshold value
(Ct) was measured in five different organs (the heart, spleen, kidney, brain
and liver) of BAGV-inoculated red-legged partridges. Closed circles indicate
viral load in partridges of the programmed necropsy group and open circles
show viral load in lethally infected partridges. A solid line represents the mean
of the data of viral load at different days post-infection.
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